Table 2. Demographic data of 10 patients of the clinical poor responders.
*Extent of AA: in accordance with the guidelines of National Alopecia Areata Foundation guidelines: S0: no hair loss, S1: <25% hair loss, S2: 26~50%, S3:51~75%, S4: 76~99%, Alopecia totalis (AT): total scalp hair loss, Alopecia universalis (AU): total scalp and body hair loss, Alopecia totalis/universalis (AT/AU): alopecia totalis with variable degrees of loss of body hair, †MTC: the mean trough concentration of cyclosporine A, ‡CsA: cyclosporin A, §MPDS: methylprednisone